Emzor Pharmaceutical Industries Limited
尼日利亚制药商，生产 Emzolyn、Emtrix 和多种基本药物。
Emzor Pharmaceutical Industries Limited 为尼日利亚医疗保健市场生产片剂、糖浆、软膏和注射剂。其产品包括止咳糖浆、镇痛药、抗疟药和营养补充剂。
- Type
- manufacturer (our classification of the record, not a statement by the company)
- Role
- Manufacturer
- Location
- Isolo, Nigeria
- Founded
- 1984
- Website
- https://www.emzorpharma.com
- Categories
- 补充剂与健康, 医疗保健用品
- Markets
- 尼日利亚, 加纳, 科特迪瓦
What is established and what is not
No facet of this company has been investigated yet. The facts below are collected records, not an assessment: nothing here confirms manufacturing, ownership or trading status beyond what each record literally says.
Verified facts
- sanctions-clear (green), checked 2026-08-08 - screened by name only: no legal entity is established for this record, so this is not a clearance OpenSanctions
- debarment-clear (green), checked 2026-08-08 - screened by name only: no legal entity is established for this record, so this is not a clearance OpenSanctions
- corporate-mail-on-domain (green), checked 2026-08-08 Mail server of the company domain
- domain-registered (green), checked 2026-08-08 Domain registry record
- web-presence-since (green), checked 2026-08-02 Internet Archive (Wayback)
Claimed certifications, not confirmed by us
- Good Manufacturing Practice
- ISO 9001, Quality Management IAF CertSearch
Import rules for these goods
- Food supplements sold in the EU follow Directive 2002/46/EC: most member states require a notification to the national authority before the first sale. European Commission (supplements)
- Medical devices sold in the EU must carry CE marking under the Medical Device Regulation (EU) 2017/745, with a conformity assessment matched to the device risk class. European Commission (MDR)
- For the US market, the maker must have an FDA device establishment registration and product listing; most instruments also need 510(k) premarket clearance. US FDA (devices)